Monday, August 31, 2020

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion

Nestle to buy Aimmune Therapeutics, valuing allergy treatment maker at $2.6 billion The offer values the California-based biopharmaceutical company at $2.6 billion, including the $473 million that Nestle had already invested in Aimmune, Nestle said in a statement.

from Moneycontrol Business News https://ift.tt/2QEFiGF

No comments:

Post a Comment

How Xi Jinping just redrew world's geopolitical map

While US Treasury Secretary Scott Bessent dismissed the SCO summit, telling Fox News it was “largely performative,” to other observers Xi ha...